The current valuation score of BioMarin Pharmaceutical Inc is 8.05, ranking 74 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is 43.02, which is 513.55% below the recent high of 263.97 and 64.44% above the recent low of 15.30.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.